Cisatracurium Besylate
Cisatracurium Besylate
11 active makers
soon
soon
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it11 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Somerset Therapeutics, LLC | unknown | 6 | SUPPLYING |
| Caplin Steriles Limited | unknown | 5 | SUPPLYING |
| Gland Pharma Limited | unknown | 3 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 3 | SUPPLYING |
| Sandoz Inc | unknown | 3 | SUPPLYING |
| Eugia US LLC | unknown | 2 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 2 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Armas Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 26, 2025RECALLRecall (Class III): Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manuf…
Subpotent product:out of specification assay results observed during long term stability testing. — Recalling firm: SOMERSET THERAPEUTICS LLC — Nationwide in the USA
- Nov 26, 2025RECALLRecall (Class III): Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactu…
Subpotent product:out of specification assay results observed during long term stability testing. — Recalling firm: SOMERSET THERAPEUTICS LLC — Nationwide in the USA
- Nov 26, 2025RECALLRecall (Class III): Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactur…
Subpotent product:out of specification assay results observed during long term stability testing. — Recalling firm: SOMERSET THERAPEUTICS LLC — Nationwide in the USA
Pill